Anupama Kottam
Cardiovascular Disease · Detroit, MINPI 1861633414
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $693 and has fallen 78.6% since, to $148 in 2024. That places this record below the midpoint for cardiovascular disease clinicians in MI, where the typical reported total is $2,775.
Across 109 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$216
- Pfizer$190
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$187
- Medtronic$175
- Irhythm Technologies, Inc.$171
- E.r. Squibb & Sons, L.L.C.$134
- plus $900 from 21 others
Across 5 payments — averaging $3150.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vifor (international) Ltd.$16K
What the payments were for
- Food & beverage$1,972100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 10 | $216 |
| Pfizer | 13 | $190 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $187 |
| Medtronic(2 entities) | 5 | $175 |
| Irhythm Technologies, Inc. | 12 | $171 |
| E.r. Squibb & Sons, L.L.C. | 9 | $134 |
| Merck | 7 | $104 |
| AstraZeneca | 6 | $83 |
| Alnylam Pharmaceuticals Inc. | 3 | $82 |
| Corcept Therapeutics | 4 | $82 |
| BD | 5 | $82 |
| Amgen | 4 | $61 |
| Novartis | 3 | $58 |
| Boehringer Ingelheim | 3 | $52 |
| Lilly USA, LLC | 3 | $41 |
| Insmed, Inc. | 2 | $33 |
| Sobi, Inc | 1 | $27 |
| Lantheus Medical Imaging, Inc. | 1 | $26 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $25 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| Bracco Diagnostics Inc. | 1 | $23 |
| Zealand Pharma US, Inc. | 1 | $20 |
| Akcea Therapeutics, Inc. | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Radius Health, Inc. | 1 | $14 |
| Electromed, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$112
How this compares
$1,972 in reported general payments places this provider in the 45th percentile of 760 cardiovascular disease providers in Michigan.
Other cardiovascular disease in Detroit
- Pedro Villablanca SpinettoDetroit$620K
- Wayne WeaverDetroit$340K
- Brian OneillDetroit$250K
- Karthikeyan AnanthasubramaniamDetroit$112K
- Gerald KoenigDetroit$96K
- David LanfearDetroit$82K
- Celeste WilliamsDetroit$70K
- Mahir ElderDetroit$68K
- Cori RussellDetroit$67K
- Pedro Engel GonzalezDetroit$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.